Items where authors include "Natarajan, A."

Article

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. ISSN 0140-6736

Lawrence, N. orcid.org/0000-0002-7686-6172, Natarajan, A., Petkar, R. et al. (1 more author) (2020) Impact of COVID-19 lockdown on glycaemic control in young people with type 1 diabetes: a retrospective review at a large hospital. Diabetes Care for Children & Young People, 10 (2). ISSN 2050-1528

Proceedings Paper

Lawrence, N.R., Natarajan, A., Petkar, R. et al. (1 more author) (2021) Impact of COVID 19 national lockdown on glycaemic control in children and adolescents with type 1 diabetes (T1DM): A retrospective review at a large UK teaching hospital. In: Journal of the Endocrine Society. Annual Meeting of the Endocrine Society (ENDO 2021), 20-23 Mar 2021, Virtual meeting. Oxford University Press , a344-a344.